The Association Between Sarcopenic Obesity and Hypertension, Diabetes, and Abnormal Lipid Metabolism in Chinese Adults
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Sarcopenic obesity is associated with several negative health outcomes. However, there are only a few studies on the relationship between SO and metabolic diseases such as diabetes, hypertension, and abnormal lipid metabolism in Chinese adults. The aim of this work was to evaluate the association between SO and hypertension, diabetes, and abnormal lipid metabolism in Chinese adults, and explore the prediction of SO using relevant anthropometric indicators. MATERIALS AND METHODS: All participants underwent a questionnaire interview for the collection of demographic data. Thereafter, they underwent physical examination for the measurement of anthropometric variables, which was performed using bioelectrical impedance analysis. Biochemical measurements were determined according to standard laboratory procedures used for the evaluation of blood parameters. RESULTS: , and the overall prevalence of SO was 65.1%. The results showed that shorter people; people with faster heart rate; heavier weight; lower waist circumference (WC), BMI, triglyceride level, total cholesterol, and low-density lipoprotein cholesterol levels; and higher high-density lipoprotein cholesterol level are at risk for SO. CONCLUSION: The prevalence of SO is high (65.1%) in Chinese adults aged 35-74 years old. The occurrence of SO is related to hypertension, diabetes, and abnormal lipid metabolism. BMI, WC, and waist-hip ratio may be predictive indicators of SO. The incidence of SO may be reduced by timely intervention and health education for persons at risk of the condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SO relates to metabolic syndrome and an increased risk of morbimortality.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Sarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Bosy‐Westphal, A., Danielzik, S., Dörhöfer, R., Later, W., Wiese, S., & Müller, M. J. (2006) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607106030004309 · Cited by 595
Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes.
Karpe, F., & Pinnick, K. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.185 · Cited by 543
Atkins, J. L., Whincup, P. H., Morris, R. W., Lennon, L. T., Papacosta, O., & Wannamethee, S. G. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12652 · Cited by 509
Batsis, J. A., Mackenzie, T. A., Barre, L. K., Lopez-Jimenez, F., & Bartels, S. J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.117 · Cited by 479
Sarcopenia and sarcopenic obesity
Choi, K. M. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.193 · Cited by 344
Research works printed but not linked: 2
- Kalinkovich, 2016, J Ageing Res Rev, 35
- Bilgin, 2019, Aging Male, 1
Cited by
The critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
Park, M., Hwang, S. Y., Kim, N. H., Kim, S. G., Choi, K. M., Baik, S. H., & Yoo, H. J. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23005 · Cited by 68
Zhou, Y., Wang, J., Yao, Q., Jian, Q.-F., & Luo, Z.-P. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.09.920 · Cited by 45
Lu, L., He, X., Song, Y., Zhuang, M., Wu, X., & Chen, N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1034542 · Cited by 32
“These results were not consistent with previous studies, which were mostly conducted in urban areas (Wagenaar et al., 2021; Yin et al., 2021).”
ResultPasdar, Y., Darbandi, M., Rezaeian, S., Najafi, F., Hamzeh, B., & Bagheri, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.705055 · Cited by 26
Tsai, C.-H., Huang, P., It, L., Chen, C., & Wu, M. H. (2022) · Aging · doi:10.18632/aging.204034 · Cited by 23
“SO is a geriatric syndrome and a critical risk factor for death among elderly [6, 7].”
BackgroundXu, C., He, L., Tu, Y., Guo, C., Lai, H., Liao, C., Lin, C., & Tu, H. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1472456 · Cited by 16
Myostatin as a plausible biomarker for early stage of sarcopenic obesity
Ishibashi, C., Nakanishi, K., Nishida, M., Shinomiya, H., Shinzawa, M., Kanayama, D., Yamamoto, R., Kudo, T., Nagatomo, I., & Yamauchi‐Takihara, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-79534-5 · Cited by 16
Hwang, J., & Park, S. (2023) · Healthcare · doi:10.3390/healthcare11212860 · Cited by 13
“To further strengthen the reliability”
Hwang, J., & Park, S. (2024) · Healthcare · doi:10.3390/healthcare12060700 · Cited by 11
“This finding is consistent with those of previous research studies [24,33,34].”
BackgroundResultFrizzled receptors and SFRP5 in lipid metabolism: Current findings and potential applications
Chu, D., & Nguyen, T.-L. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.025 · Cited by 10
Hwang, J. (2024) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2024.19.1.43 · Cited by 12
Cao, X., Yang, B., & Zhou, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1166341 · Cited by 10
“Reduced social activity and limited social interactions imply restricting social connections, whichmay result in the development of cognitive decline (Sun et al., 2021; Yang et al., 2021; Yin et al., 2021).”
BackgroundHwang, J. (2023) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2023.18.2.13 · Cited by 10
Hwang, J. (2023) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2023.18.3.1 · Cited by 10
Hwang, J., & Moon, I.-Y. (2023) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2023.18.3.11 · Cited by 9
Qiu, J., Yang, X., Wang, Q., Yang, X., Ma, S., Zhang, J., Liu, W., Li, X., Chen, K., Wang, K., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02359-8 · Cited by 11
“S1, and the detailed recruitment process for the study population is described in our previously published article [20–24].”
MethodSelf-citationSarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women
Park, J. Y., Chung, Y., Song, J., Kil, K., Lee, H. Y., Chae, J., & Kim, J.-H. (2024) · Journal of Menopausal Medicine · doi:10.6118/jmm.24004 · Cited by 12
Analyzing Proportion and Susceptibility Markers of Sarcopenia In Korean Younger Female
Hwang, J. (2023) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2023.18.4.19 · Cited by 8
Xiao, H., Hu, L., Xie, M., Du, Y., & Liao, D. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1382254 · Cited by 9
Shen, L., Chen, S., Guo, H., Wang, Z., Yang, J. O., Chen, K., & Yuan, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1574070 · Cited by 8
Yang, B., Lian, L., Xing, K., Cen, Y., Zhao, Y., & Zhang, Y. (2025) · Nutrients · doi:10.3390/nu17193155 · Cited by 15
Self-citationDu, R., Yuan, J., Huang, Y., Jiang, G., Duan, Z., Yang, H., & Huang, W. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1479169 · Cited by 8
“Another cross-sectional study, also from northern China, including 1,082 participants (33), found that men of advanced age, physical inactivity, diabetes mellitus, and absence of hypertension may have a higher prevalence of sarcopenia, and this study had a smaller sample size and was limited to the local area of Bengb…”
InfluentialType 2 diabetes: is obesity for diabetic retinopathy good or bad? A cross-sectional study
Chen, Z., Zhong, X., Lin, R., Liu, S., Cao, H., Chen, H., Cao, B., Tu, M., & Wei, W. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00842-8 · Cited by 5
“An increasing body of evidence indicates that diabetes is linked to a heightened risk of sarcopenic obesity [14,40].”
Factors Influencing Age-Related Loss of Skeletal Muscle Mass in Young Korean Men
Hwang, J., & Lee, J.-K. (2023) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2023.18.4.67 · Cited by 5
Hwang, J. (2023) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2023.18.4.37 · Cited by 4
Landscape and research trends of sarcopenic obesity research: A bibliometric analysis
Tang, H., Lian, R., Li, R., Jiang, J., & Yang, M. J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24696 · Cited by 3
“Yin et al. [9] found that the occurrence of SO was related to hypertension, diabetes, and abnormal lipid metabolism.”
BackgroundSarcopenic Obesity as a Risk Factor for Cardiovascular Disease: An Underrecognized Clinical Entity
Binu, A. J., Kapoor, N., Bhattacharya, S., Kishor, K., & Kalra, S. (2023) · Heart International · doi:10.17925/hi.2023.17.2.4 · Cited by 4
Chen, X., Zhu, M., Cao, J., Zuo, D., Chen, Z., Weng, Y., Jiang, H., & Hu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1431036 · Cited by 3
Sarcopenic Obesity in Adult Patients: Prevalence and Risk Factors
Khamassi, S., Boukhayatia, F., Abdesselem, H., Bornaz, E., Ounaissa, K., Bouhajja, H., Kacem, A., Gammoudi, A., Mahjoub, R., Talbi, E., et al. (2025) · Nutrition and Metabolic Insights · doi:10.1177/11786388251348955 · Cited by 2
Hwang, J. (2024) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2024.19.1.31 · Cited by 3
Ren, X., Pan, R., Li, Z., & He, L. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03310-7 · Cited by 2
The Interplay of Sarcopenic Obesity and Mental Health: A Complex Relationship
Cheah, L. J., & Cheah, K. J. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004582 · Cited by 3
Mechanisms of cognitive impairment in arterial hypertension
Kotlyarov, S. N. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i7.106597 · Cited by 1
Li, X., Ding, J., Fang, Z., Shi, J., Zhou, X., Zhang, S., Li, C., Huang, P., & Lin, H. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.126835 · Cited by 1
Assessment and Management of Ischaemic Heart Disease in Non-Cardiac Surgery
Morgan, H., Ezad, S. M., Rahman, H., Silva, K. D., Partridge, J. S. L., & Perera, D. (2023) · Heart International · doi:10.17925/hi.2023.17.2.6 · Cited by 4
Sakr, B. (2021) · Evidence Based Women s Health Journal · doi:10.21608/ebwhj.2021.78011.1139
“Obesity has become widespread in the world and has attracted attention not only for being a cause of diabetes mellitus (DM)[1], hypertension and atherosclerotic diseases[2], but also as a factor in carcinogenesis[3] and for being associated with increased risk of mortality[4,5].”
BackgroundChen, W.-H., Yang, C., Shi, S., Li, Z., Xu, M., Qian, J., Li, J., & Huang, R. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf106
Hwang, J., & Hwang, J. (2025) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2025.20.4.85 · Cited by 1
Zhao, B., Li, H., Bao, L., Xu, S., Lai, H., Shi, X., & Yang, L. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.102990
Gu, Z., Mou, C., Chen, F., Zhou, K., Li, Q., Fu, S., ZHENG, S., Li, S., & Peng, R. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1880656 · Cited by 1
Exploration of cytokines relating to masked obesity in Japanese women
Ishibashi, C., Nakanishi, K., Nishida, M., Masuyama, K., Shinzawa, M., Kanayama, D., Yamamoto, R., Moriyama, T., Nagatomo, I., & Yamauchi‐Takihara, K. (2026) · Endocrine · doi:10.1007/s12020-026-04788-0
“Criteria for skeletal muscle mass reduction were defined as SMI 5.7 kg/m² according to the Asian Working Group for Sarcopenia (AWGS) standards, derived from the lower two standard deviations (SD) of young adult averages [23 , 24 ].”
InfluentialZeng, S., & Zheng, W. (2026) · International Conference on Biomedical and Intelligent Systems (IC-BIS) · doi:10.1145/3841905.3842004
Metadata
- Authors
- Yin, T., Zhang, J.-X., Wang, F.-X., Zhao, J.-H., Zhao, Y., Liu, L., Liu, X.-Y., Zhang, Y.-H., & Zhao, Y.
- Affiliations
- Ningxia Medical University (CN)
- Venue
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2021-04
- Volume
- Volume 14
- Pages
- 1963-1973
- ISSN
- 1178-7007 (ISSN-L)
- PMC
- PMC8096416
- OpenAlex
- W3157106684
- Cited by
- 44
- References
- 44
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 12 · 2023: 12 · 2022: 6 · 2021: 2
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (12061058)
- Natural Science Foundation of Ningxia Province
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenic obesity, hypertension, diabetes mellitus, abnormal lipid metabolism, Chinese adults, anthropometric predictors, waist circumference, body mass index, waist-to-hip ratio, heart rate, triglycerides, cholesterol, prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

